Stopeck A - Search Results

1

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.

Theilmann RJ, Borders R, Trouard TP, Xia G, Outwater E, Ranger-Moore J, Gillies RJ, Stopeck A. Theilmann RJ, et al. Among authors: stopeck a. Neoplasia. 2004 Nov-Dec;6(6):831-7. doi: 10.1593/neo.03343. Neoplasia. 2004. PMID: 15720810 Free PMC article.

2

Diffusion MRI with Semi-Automated Segmentation Can Serve as a Restricted Predictive Biomarker of the Therapeutic Response of Liver Metastasis.

Stephen RM, Jha AK, Roe DJ, Trouard TP, Galons JP, Kupinski MA, Frey G, Cui H, Squire S, Pagel MD, Rodriguez JJ, Gillies RJ, Stopeck AT. Stephen RM, et al. Among authors: stopeck at. Magn Reson Imaging. 2015 Dec;33(10):1267-1273. doi: 10.1016/j.mri.2015.08.006. Epub 2015 Aug 15. Magn Reson Imaging. 2015. PMID: 26284600 Free PMC article.

3

Radial fast spin-echo method for T2-weighted imaging and T2 mapping of the liver.

Altbach MI, Outwater EK, Trouard TP, Krupinski EA, Theilmann RJ, Stopeck AT, Kono M, Gmitro AF. Altbach MI, et al. Among authors: stopeck at. J Magn Reson Imaging. 2002 Aug;16(2):179-89. doi: 10.1002/jmri.10142. J Magn Reson Imaging. 2002. PMID: 12203766

4

Task-based evaluation of segmentation algorithms for diffusion-weighted MRI without using a gold standard.

Jha AK, Kupinski MA, Rodríguez JJ, Stephen RM, Stopeck AT. Jha AK, et al. Among authors: stopeck at. Phys Med Biol. 2012 Jul 7;57(13):4425-46. doi: 10.1088/0031-9155/57/13/4425. Epub 2012 Jun 20. Phys Med Biol. 2012. PMID: 22713231 Free PMC article.

5

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer.

Chalasani P, Marron M, Roe D, Clarke K, Iannone M, Livingston RB, Shan JS, Stopeck AT. Chalasani P, et al. Cancer Med. 2015 Jul;4(7):1051-9. doi: 10.1002/cam4.447. Epub 2015 Mar 31. Cancer Med. 2015. PMID: 25826750 Free PMC article. Clinical Trial.

6

The role of targeted therapy and biomarkers in breast cancer treatment.

Stopeck AT, Brown-Glaberman U, Wong HY, Park BH, Barnato SE, Gradishar WJ, Hudis CA, Rugo HS. Stopeck AT, et al. Clin Exp Metastasis. 2012 Oct;29(7):807-19. doi: 10.1007/s10585-012-9496-y. Epub 2012 Jun 13. Clin Exp Metastasis. 2012. PMID: 22692561 Review.

7

A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer.

Segar JM, Reed D, Stopeck A, Livingston RB, Chalasani P. Segar JM, et al. Among authors: stopeck a. Oncologist. 2019 Dec;24(12):1512-e1267. doi: 10.1634/theoncologist.2019-0516. Epub 2019 Aug 5. Oncologist. 2019. PMID: 31383812 Free PMC article. Clinical Trial.

8

Denosumab findings in metastatic breast cancer.

Stopeck A. Stopeck A. Clin Adv Hematol Oncol. 2010 Mar;8(3):159-60. Clin Adv Hematol Oncol. 2010. PMID: 20400929 No abstract available.

9

Circulating Carbonic Anhydrase IX and Antiangiogenic Therapy in Breast Cancer.

Brown-Glaberman U, Marron M, Chalasani P, Livingston R, Iannone M, Specht J, Stopeck AT. Brown-Glaberman U, et al. Dis Markers. 2016;2016:9810383. doi: 10.1155/2016/9810383. Epub 2016 Jan 28. Dis Markers. 2016. PMID: 26941473 Free PMC article.

10

A pilot study of estradiol followed by exemestane for reversing endocrine resistance in postmenopausal women with hormone receptor-positive metastatic breast cancer.

Chalasani P, Stopeck A, Clarke K, Livingston R. Chalasani P, et al. Among authors: stopeck a. Oncologist. 2014 Nov;19(11):1127-8. doi: 10.1634/theoncologist.2014-0306. Epub 2014 Sep 26. Oncologist. 2014. PMID: 25260365 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters